Evidence map›Paper›PMID 36678322›Full record

ReviewNutrients2023

Neuroprotective Effects of Agri-Food By-Products Rich in Phenolic Compounds.

Alejandro Rojas-García, Álvaro Fernández-Ochoa, María de la Luz Cádiz-Gurrea, David Arráez-Román, Antonio Segura-Carretero

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Frontiers in pharmacology · 2026
    Article
  10. Review
  11. Review
  12. Repurposing 1,4-Dihydropyridine Scaffold: 4-Imidazo[2,1-Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  13. Review
  14. Review
  15. Exploring the Neuroprotective Properties of Celery (Molecules (Basel, Switzerland) · 2025
    Article
  16. Review
  17. Review
  18. Article
  19. Phenolic Compounds and Pharmacological Potential ofPlants (Basel, Switzerland) · 2025
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Alejandro Rojas-GarcíaDepartment of Analytical Chemistry, University of Granada, 18071 Granada, Spain.ORCID 0000-0002-7020-2017
Álvaro Fernández-OchoaDepartment of Analytical Chemistry, University of Granada, 18071 Granada, Spain.ORCID 0000-0001-5547-3209
María de la Luz Cádiz-GurreaDepartment of Analytical Chemistry, University of Granada, 18071 Granada, Spain.ORCID 0000-0002-2613-4889
David Arráez-RománDepartment of Analytical Chemistry, University of Granada, 18071 Granada, Spain.ORCID 0000-0003-1267-6676
Antonio Segura-CarreteroDepartment of Analytical Chemistry, University of Granada, 18071 Granada, Spain.ORCID 0000-0002-5564-5338
Universidad de Granada · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurodegenerative diseases are known for their wide range of harmful conditions related to progressive cell damage, nervous system connections and neuronal death. These pathologies promote the loss of essential motor and cognitive functions, such as mobility, learning and sensation. Neurodegeneration affects millions of people worldwide, and no integral cure has been created yet. Here, bioactive compounds have been proven to exert numerous beneficial effects due to their remarkable bioactivity, so they could be considered as great options for the development of new neuroprotective strategies. Phenolic bioactives have been reported to be found in edible part of plants; however, over the last years, a large amount of research has focused on the phenolic richness that plant by-products possess, which sometimes even exceeds the content in the pulp. Thus, their possible application as an emergent neuroprotective technique could also be considered as an optimal strategy to revalorize these agricultural residues (those originated from plant processing). This review aims to summarize main triggers of neurodegeneration, revise the state of the art in plant extracts and their role in avoiding neurodegeneration and discuss how their main phenolic compounds could exert their neuroprotective effects. For this purpose, a diverse search of studies has been conducted, gathering a large number of papers where by-products were used as strong sources of phenolic compounds for their neuroprotective properties. Finally, although a lack of investigation is quite remarkable and greatly limits the use of these compounds, phenolics remain attractive for research into new multifactorial anti-neurodegenerative nutraceuticals.

Indexed as

Neurodegenerative DiseasesNeuroprotective AgentsAntioxidantsHumansPhenolsPlant ExtractsPlantsAntioxidantsNeuroprotective AgentsPhenolsPlant ExtractsAChEmitochondrial dysfunctionneurodegenerationneuroinflammationneuroprotectionoxidative stressphenolic compoundsplant by-productsprotein aggregation

Identifiers

PMID36678322
PMCPMC9865516
OpenAlexW4316465927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.